BRPI0517285A - nitrobenzindóis e seu emprego na terapia de cáncer - Google Patents
nitrobenzindóis e seu emprego na terapia de cáncerInfo
- Publication number
- BRPI0517285A BRPI0517285A BRPI0517285-3A BRPI0517285A BRPI0517285A BR PI0517285 A BRPI0517285 A BR PI0517285A BR PI0517285 A BRPI0517285 A BR PI0517285A BR PI0517285 A BRPI0517285 A BR PI0517285A
- Authority
- BR
- Brazil
- Prior art keywords
- cancer therapy
- nitrobenzindoles
- drugs
- nitrobenzinds
- radiosensitizers
- Prior art date
Links
- 238000011275 oncology therapy Methods 0.000 title abstract 3
- GNDINQYCDXTGEO-UHFFFAOYSA-N 2-nitro-1h-benzo[g]indole Chemical class C1=CC=CC2=C(NC([N+](=O)[O-])=C3)C3=CC=C21 GNDINQYCDXTGEO-UHFFFAOYSA-N 0.000 title 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ536107A NZ536107A (en) | 2004-10-22 | 2004-10-22 | Nitrobenzindoles and their use in cancer therapy |
| PCT/NZ2005/000278 WO2006043839A1 (en) | 2004-10-22 | 2005-10-21 | Nitrobenzindoles and their use in cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0517285A true BRPI0517285A (pt) | 2008-10-07 |
Family
ID=36203204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0517285-3A BRPI0517285A (pt) | 2004-10-22 | 2005-10-21 | nitrobenzindóis e seu emprego na terapia de cáncer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7718688B2 (https=) |
| EP (1) | EP1809603A4 (https=) |
| JP (1) | JP2008517905A (https=) |
| KR (1) | KR20070083806A (https=) |
| CN (1) | CN101044114B (https=) |
| AU (1) | AU2005296389B2 (https=) |
| BR (1) | BRPI0517285A (https=) |
| CA (1) | CA2584702A1 (https=) |
| IL (1) | IL182652A0 (https=) |
| MX (1) | MX2007004596A (https=) |
| NZ (1) | NZ536107A (https=) |
| RU (1) | RU2007118938A (https=) |
| WO (1) | WO2006043839A1 (https=) |
| ZA (1) | ZA200703699B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1994000B1 (en) * | 2006-02-02 | 2017-08-23 | Syntarga B.V. | Water-soluble cc-1065 analogs and their conjugates |
| US9901567B2 (en) | 2007-08-01 | 2018-02-27 | Syntarga B.V. | Substituted CC-1065 analogs and their conjugates |
| US8076491B2 (en) | 2007-08-21 | 2011-12-13 | Senomyx, Inc. | Compounds that inhibit (block) bitter taste in composition and use thereof |
| KR101558193B1 (ko) | 2007-08-21 | 2015-10-12 | 세노믹스, 인코포레이티드 | 인간 ｔ2ｒ 쓴맛 수용체 및 이의 용도 |
| NZ571028A (en) * | 2008-09-03 | 2011-01-28 | Auckland Uniservices Ltd | Nitrobenzindole compounds and their use in cancer treatment |
| AU2009320481C1 (en) | 2008-11-03 | 2016-12-08 | Syntarga B.V. | Novel CC-1065 analogs and their conjugates |
| AU2011243294C1 (en) | 2010-04-21 | 2015-12-03 | Syntarga B.V. | Novel conjugates of CC-1065 analogs and bifunctional linkers |
| CN102827061A (zh) * | 2012-09-19 | 2012-12-19 | 兰州大学 | 5,6,7-三甲氧基吲哚类衍生物、制备方法及用途 |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| AU2015205574B2 (en) | 2014-01-10 | 2019-08-15 | Byondis B.V. | Method for purifying Cys-linked antibody-drug conjugates |
| HUE029672T2 (en) | 2014-01-10 | 2017-03-28 | Synthon Biopharmaceuticals Bv | Duokarmicin-ADCs for use in the treatment of endometrial cancer |
| CN105899236B (zh) | 2014-01-10 | 2019-07-26 | 斯索恩生物制药有限公司 | 表现出改进的体内抗肿瘤活性的倍癌霉素adc |
| EP3160513B1 (en) | 2014-06-30 | 2020-02-12 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| JPWO2019004413A1 (ja) * | 2017-06-30 | 2020-05-07 | 東レ株式会社 | インドリン誘導体及びそれを含む細胞毒性剤 |
| CN112724068A (zh) * | 2020-12-30 | 2021-04-30 | 蔡桂坡 | 具有hdac抑制活性的吲哚类衍生物的合成方法及肿瘤应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ334344A (en) | 1996-09-12 | 2000-08-25 | Cancer Res Campaign Tech | benzo[e]indole and pyrrolo[3,2-e]indole compounds and their use as prodrugs |
| JP4862120B2 (ja) * | 2001-02-22 | 2012-01-25 | ユニヴァーシティ オブ ブラッドフォード | 腫瘍治療のためのプロドラッグとしてのベンズ−インドールおよびベンゾ−キノリン誘導体 |
| WO2003097635A1 (en) * | 2002-05-17 | 2003-11-27 | Auckland Uniservices Limited | Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl(amine-derived)] compounds and analogues thereof, and to products obtained therefrom |
| NZ529249A (en) | 2003-10-31 | 2006-04-28 | Auckland Uniservices Ltd | Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic |
-
2004
- 2004-10-22 NZ NZ536107A patent/NZ536107A/en not_active IP Right Cessation
-
2005
- 2005-10-21 JP JP2007537835A patent/JP2008517905A/ja active Pending
- 2005-10-21 CN CN2005800362035A patent/CN101044114B/zh not_active Expired - Fee Related
- 2005-10-21 CA CA002584702A patent/CA2584702A1/en not_active Abandoned
- 2005-10-21 US US11/666,014 patent/US7718688B2/en not_active Expired - Fee Related
- 2005-10-21 BR BRPI0517285-3A patent/BRPI0517285A/pt not_active Application Discontinuation
- 2005-10-21 AU AU2005296389A patent/AU2005296389B2/en not_active Ceased
- 2005-10-21 WO PCT/NZ2005/000278 patent/WO2006043839A1/en not_active Ceased
- 2005-10-21 MX MX2007004596A patent/MX2007004596A/es not_active Application Discontinuation
- 2005-10-21 RU RU2007118938/04A patent/RU2007118938A/ru not_active Application Discontinuation
- 2005-10-21 KR KR1020077009468A patent/KR20070083806A/ko not_active Ceased
- 2005-10-21 EP EP05800725A patent/EP1809603A4/en not_active Withdrawn
-
2007
- 2007-04-18 IL IL182652A patent/IL182652A0/en unknown
- 2007-05-08 ZA ZA200703699A patent/ZA200703699B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ536107A (en) | 2007-06-29 |
| US7718688B2 (en) | 2010-05-18 |
| US20080119442A1 (en) | 2008-05-22 |
| EP1809603A1 (en) | 2007-07-25 |
| JP2008517905A (ja) | 2008-05-29 |
| CN101044114B (zh) | 2012-02-15 |
| CN101044114A (zh) | 2007-09-26 |
| CA2584702A1 (en) | 2006-04-27 |
| AU2005296389A1 (en) | 2006-04-27 |
| AU2005296389B2 (en) | 2012-03-15 |
| EP1809603A4 (en) | 2009-09-02 |
| WO2006043839A1 (en) | 2006-04-27 |
| IL182652A0 (en) | 2007-07-24 |
| KR20070083806A (ko) | 2007-08-24 |
| RU2007118938A (ru) | 2008-11-27 |
| MX2007004596A (es) | 2007-06-22 |
| ZA200703699B (en) | 2008-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0517285A (pt) | nitrobenzindóis e seu emprego na terapia de cáncer | |
| BRPI0622073A8 (pt) | Uso de anticorpos pdgfralfa para fabricação de um medicamento para tratar um tumor ósseo | |
| BRPI0911442A2 (pt) | conjugados potentes e ligantes hidrofílicos | |
| WO2009054996A8 (en) | Systems and methods for viral therapy | |
| PE20160953A1 (es) | Anticuerpo pd-1, fragmento de union al antigeno de este y uso medico de este | |
| MX2015007343A (es) | Dosis de inmunoconjugados de anticuerpos y sn-38 para eficacia mejorada y toxicidad reducida. | |
| NZ711373A (en) | Fragments of p97 and uses thereof | |
| BRPI0509201A (pt) | agentes de acoplamento de receptor e usos terapêuticos destes | |
| CL2014001792A1 (es) | Compuestos derivados de carbamato; composicion farmaceutica, y uso de los mismos en el tratamiento del dolor, cancer por tumor solido, obesidad, entre otras enfermedades. | |
| CR10996A (es) | Metodo de tratamiento del cancer mediante administracion de combinaciones de il-18 humana | |
| WO2013188847A8 (en) | Compositions and methods for transmucosal absorption | |
| BRPI0511420A (pt) | fosforodiamidatos de sulfoniletila | |
| MY145089A (en) | Pharmaceutical composition | |
| BR112013020265A2 (pt) | formas de rifaximina e uso das mesmas | |
| BRPI0818690A2 (pt) | Derivados de quinazolinediona, sua preparação e seus usos terapêuticos. | |
| WO2009142738A3 (en) | Compositions and methods for diagnosing and treating cancer | |
| BR112013032766A2 (pt) | "compostos de ligação com catepsina, composto que visa catepsina, processo para a preparação dos referidos compostos e usos dos mesmos na preparação de medicamentos | |
| WO2006053049A3 (en) | Herbal composition phy906 and its use in chemotherapy | |
| MX2009003039A (es) | Utilizacion de un anticuerpo anti-cd151 para el tratamiento del cancer. | |
| ZA201001085B (en) | Indol-2-one derivatives disubstituted in the 3-position,preparation thereof and therapeutic use thereof | |
| BR112014018450A8 (pt) | Fenilimidazopirazoles substituídos e sua utilização | |
| AR066778A1 (es) | Terapia combinada para el tratamiento del cancer que comprende vinflunina y trastuzumab | |
| PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso | |
| PT1827500E (pt) | Doxorrubicina pegilada lipossomal em combinação com ecteinescidina 743 | |
| CL2008000675A1 (es) | Compuestos derivados de heterociclos sulfonilados; metodo para preparar dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer de mama, entre otras enfermedades. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |